Skip to content

The effect of continuous femoral nerve block on analgesia programme following total knee arthroplasty: a clinical study

The effect of continuous femoral nerve block on analgesia programme following total knee arthroplasty: a clinical study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOD-17012678
Enrollment
Unknown
Registered
2017-09-15
Start date
2017-10-01
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee arthritis

Interventions

0.1%:0.1% ropivacine femoral nerve block
0.15%:0.15% ropivacine femoral nerve block
0.2%:0.2% ropivacine femoral nerve block

Sponsors

The First Affiliated Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Adults (40–80 yr) scheduled to undergo primary, unilateral, tricompartment, cemented TKA via a 12- to 18-cm midline skin incision and parapatellar approach who desired a cFNB for postoperative analgesia.

Exclusion criteria

Exclusion criteria: A history of opioid dependence or current chronic analgesic therapy (daily use>4 weeks), allergy to study medications, known hepatic or renalinsufficiency/disease, peripheral neuropathy, morbid obesity (body mass index >40 kg/m2), pregnancy, incarceration,or comorbidity that resulted in moderate or severe functional limitation.

Design outcomes

Primary

MeasureTime frame
pain VAS;physical therapy;morphine consumption;time to attain three discharge criteri;

Secondary

MeasureTime frame
patient satisfaction;sleeping quality;

Countries

China

Contacts

Public ContactKjian Shi

The First Affiliated Hospital of Wenzhou Medical University

wzshikejian@163.com+86 13868889697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026